Results 201 to 210 of about 18,286 (260)

Endocrine consequences of antifungal therapy: A missed entity. [PDF]

World J Clin Cases
Thakkar S, Kantroo V, Nagendra L, Dutta D, Kamrul-Hasan ABM, Kalra S, Bhattacharya S.   +6 more
europepmc   +1 more source

Population-based estimates of the global prevalence and carrier frequency of apparent mineralocorticoid excess caused by 11β-hydroxysteroid dehydrogenase type 2 deficiency. [PDF]

Orphanet J Rare Dis
Charoenngam N, Kansuttiviwat C, Chinsawangwatanakul P.   +2 more
europepmc   +1 more source

Complete glucocorticoid resistance: a lethal disorder in the neonatal period. [PDF]

JCEM Case Rep
Segev N, Swauger S, Weaver KN, Jain S, Patel KR, Backeljauw P.   +5 more
europepmc   +1 more source

Stable-isotope tracing reveals the role of corticosteroid receptors in driving cortisol-mediated central and peripheral glucose regulation in zebrafish. [PDF]

Front Endocrinol (Lausanne)
Antomagesh F, Vijayan MM.
europepmc   +1 more source

Exogenous corticosteroid-induced modulation of RAAS: potential implications for septic shock biomarker analysis. [PDF]

Ann Intensive Care
Uslar T, Sanfuentes B, Baudrand R, Hernández G, Kattan E.   +4 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

The Multifaceted Mineralocorticoid Receptor

Comprehensive Physiology, 2014
Abstract The primary adrenal cortical steroid hormones, aldosterone, and the glucocorticoids cortisol and corticosterone, act through the structurally similar mineralocorticoid (MR) and glucocorticoid receptors (GRs). Aldosterone is crucial for fluid, electrolyte, and hemodynamic homeostasis and tissue repair; the
Elise, Gomez-Sanchez, Celso E, Gomez-Sanchez   +1 more
openaire   +2 more sources

Mineralocorticoid receptor antagonists

Current Hypertension Reports, 2007
With an increasingly aging population, the need for effective treatment of cardiovascular diseases (eg, heart failure, hypertension, and ischemic heart disease) cannot be overemphasized. The vital importance of mineralocorticoid receptor antagonists for treating cardiovascular conditions has only been appreciated in the last decade. The re-emergence of
Parthasarathy, Hari Krishnan, MacDonald, Thomas M.   +1 more
openaire   +3 more sources